Related Experiment Video
Updated: Jun 17, 2025

07:16
Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells
Published on: January 21, 2021
3.0K
Biomodulatory Effects of Molecular Delivery in Human T Cells Using 3D-Printed Acoustofluidic Devices
Connor S Centner1, Clinton J Belott2, Riyakumari K Patel1
1Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Ultrasound in Medicine & Biology
|August 6, 2024
Summary
Novel 3D-printed acoustofluidic devices enhance molecular delivery to human T cells via sonoporation. This technology offers a faster, more efficient non-viral method for cell therapy manufacturing.
Area of Science:
- Biotechnology
- Cell Biology
- Bioengineering
Background:
- Cell-based therapies show promise for treating diseases like cancer.
- Current manufacturing relies on viral transduction, facing efficiency and time limitations.
- Non-viral transfection methods also struggle with variability and low delivery efficiency.
Purpose of the Study:
- To assess biological parameters influencing ultrasound-mediated molecular delivery to human T cells using acoustofluidics.
- To evaluate the potential of 3D-printed acoustofluidic devices for non-viral cell therapy processing.
Main Methods:
- Utilized flow cytometry and confocal imaging to analyze fluorescent molecule delivery (calcein, FITC-Dextran) to human T cells.
- Investigated effects of cell plating density, cell cycle phase, and calcium chelation (EGTA) on molecular delivery.
- Examined the role of the actin cytoskeleton and nuclear membrane permeability post-sonoporation.
Main Results:
- Lower cell plating densities (100,000 cells/mL) significantly improved molecular delivery.
- Cells in the S phase of the cell cycle exhibited enhanced intracellular delivery and viability.
- EGTA reduced molecular delivery, and actin cytoskeleton dynamics influenced membrane recovery.
- Acoustofluidic treatment demonstrated potential for nuclear membrane permeabilization.
Conclusions:
- 3D-printed acoustofluidic devices effectively enhance molecular delivery to human T cells.
- Optimized parameters like cell density and cell cycle phase improve non-viral transfection efficiency.
- This technology presents a promising avenue for advancing non-viral cell therapy manufacturing processes.
Keywords:
AcoustofluidicsCell therapiesLymphocytesMicrobubblesMolecular deliverySonoporationT cellsUltrasound
